• Astrazeneca.

    Palù (Aifa): beware of women who take birth control pills

  • Hope: the AstraZeneca case does not undermine confidence in vaccines, answers from Ema already tomorrow

  • Doubts and fear spread across the American continent over the AstraZeneca vaccine

  • Von der Leyen: "On export vaccines we want reciprocity. I trust AstraZeneca, Ema will clarify"

Share

March 18, 2021 Ema's pronouncement on AstraZeneca, the vaccine suspended as a precaution in several European countries after alleged adverse reactions had been reported, is expected this afternoon.



Barring last-minute surprises, the regulatory body should decide to resume vaccinations with the Anglo-Swedish product.

Serum that the WHO, in a note yesterday, reiterated to be a key player in the fight against the pandemic.

According to the World Health Organization, there is no doubt that the benefits of AstraZeneca currently outweigh its risks, as thromboembolic events related to the administration of this drug, the WHO warns, "occur frequently. Thrombus. -venous embolism is the third most common cardiovascular disease in the world ".



 It is not excluded that this concept will be reiterated again this morning at 11, during the press conference in which the European regional director Henry Kluge will take stock of the pandemic situation in the old continent: a meeting in which the hot topics seem destined to be precisely the fate of AstraZeneca and the now like wildfire spread of the variants of the virus, which in some countries have now taken over.

This is the case in Germany, where more than 70% of infections are now attributable to the British strain.




Even the president of the EU, Ursula Von der Leyen, rejected the doubts about the safety of the drug produced by AstraZeneca, stressing that her evaluation, before the vaccination campaign was launched, "was very rigorous, I trust Ema and tomorrow (today for the reader, ed) will clarify the situation ".

The most likely scenario is that the European regulator reaffirms the total reliability of the vaccine, implicitly recommending to the sixteen governments that have decided to suspend to resume administration.

However, it is also possible that some recommendations will be added in the so-called "leaflet".

Even the Italian health authorities have expressed their most convinced confidence in the positive outcome of the affair.